Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
Sara Gaafar Ibnauf Suliman, President of Obesity Medicine Section at IFSO International Federation for the Surgery and other therapies for Obesity (IFSO), shared a post on LinkedIn:
“GLP1 receptor agonist usage has expanded exponentially, making some question the role of metabolic bariatric surgery (MBS) in the management of obesity.
In this article published today in the The Lancet Obstetrics, Gynaecology, and Women’s Health we present a balanced view on why both MBS and GLP1RAs have an important role to play in the management of obesity and particularly in women.”
Title: Obesity medications in women’s health: is metabolic bariatric surgery still relevant?
Authors: Sara G I Suliman, Ali Aminian, Mohammed Al-Hadad, Alexander Dimitri Miras, Dimitris Papamargaritis, Melanie J Davies, Susan E Ozanne, Claire L Meek, Tricia M-M Tan

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines